RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of … Continue reading “CBDNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights”
RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful data insights and is on a mission to transform patient care using big data and AI to reshape the understanding and uses of plant-based medicines. The company’s devices and data are being used by a rapidly growing number of participants in plant-based clinical trials … Continue reading “CBDNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results”
RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer … Continue reading “RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects”
RYAH Group (CSE: RYAH) is a leading data technology company in plant-based medicine committed to providing valuable insight and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company is working to unearth breakthrough discoveries that will reshape the understanding of … Continue reading “CBDNewsBreaks – RYAH Group Inc. (CSE: RYAH) Unearthing Breakthrough Discoveries That Will Reshape Understanding of Plant-Based Medicines”
Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatment The viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intake RYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb Inhaler The company successfully delivered on … Continue reading “RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment”
Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal … Continue reading “RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market”
German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH … Continue reading “German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study”
RYAH Group (CSE: RYAH), a connected device and big data and technology company, in a recent blog post provided insight into the cannabis medical space in Brazil, the largest South American country both in size and population, boasting a GDP per capita of $15,388. A recent article that contains excerpts from the post notes that … Continue reading “CBDNewsBreaks – RYAH Group Inc. (CSE: RYAH) Well Qualified to Provide Global Insight into Medical Cannabis”
Palliative care focuses on providing end-of-life care for chronically ill patients Preliminary research suggests cannabis relieves pain, appetite loss, anxiety RYAH is the leader in volume-control technology for plant-based medicine RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data With a mission to advance remote-health solutions and analytics-based patient … Continue reading “RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions”
RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate … Continue reading “CBDNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices”
